JP2008521884A5 - - Google Patents

Download PDF

Info

Publication number
JP2008521884A5
JP2008521884A5 JP2007544016A JP2007544016A JP2008521884A5 JP 2008521884 A5 JP2008521884 A5 JP 2008521884A5 JP 2007544016 A JP2007544016 A JP 2007544016A JP 2007544016 A JP2007544016 A JP 2007544016A JP 2008521884 A5 JP2008521884 A5 JP 2008521884A5
Authority
JP
Japan
Prior art keywords
sodium
composition
ceftriaxone
sulbactam
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007544016A
Other languages
English (en)
Japanese (ja)
Other versions
JP5269415B2 (ja
JP2008521884A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IN2005/000382 external-priority patent/WO2006059344A1/en
Publication of JP2008521884A publication Critical patent/JP2008521884A/ja
Publication of JP2008521884A5 publication Critical patent/JP2008521884A5/ja
Application granted granted Critical
Publication of JP5269415B2 publication Critical patent/JP5269415B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007544016A 2004-12-02 2005-11-28 注射に有用なβ−ラクタマーゼ阻害剤を使用したβ−ラクタマーゼ媒介性の抗生物質耐性を抑制する組成物 Expired - Fee Related JP5269415B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2411DE2004 2004-12-02
IN2411/DEL/2004 2004-12-02
PCT/IN2005/000382 WO2006059344A1 (en) 2004-12-02 2005-11-28 Compositions for combating beta-lactamase-mediated antibiotic resistance using beta-lactamase inhibitors useful for injection

Publications (3)

Publication Number Publication Date
JP2008521884A JP2008521884A (ja) 2008-06-26
JP2008521884A5 true JP2008521884A5 (https=) 2008-12-18
JP5269415B2 JP5269415B2 (ja) 2013-08-21

Family

ID=35789266

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007544016A Expired - Fee Related JP5269415B2 (ja) 2004-12-02 2005-11-28 注射に有用なβ−ラクタマーゼ阻害剤を使用したβ−ラクタマーゼ媒介性の抗生物質耐性を抑制する組成物

Country Status (23)

Country Link
US (2) US8273732B2 (https=)
EP (1) EP1841432B1 (https=)
JP (1) JP5269415B2 (https=)
KR (2) KR101244362B1 (https=)
CN (1) CN101060846A (https=)
AT (1) ATE476981T1 (https=)
AU (1) AU2005310888B2 (https=)
BR (1) BRPI0517128A (https=)
CY (1) CY1110886T1 (https=)
DE (1) DE602005022939D1 (https=)
DK (1) DK1841432T3 (https=)
ES (1) ES2349301T3 (https=)
HR (1) HRP20100591T1 (https=)
MX (1) MX2007006540A (https=)
NZ (1) NZ555075A (https=)
PL (1) PL1841432T3 (https=)
PT (1) PT1841432E (https=)
RS (1) RS51506B (https=)
RU (1) RU2397768C2 (https=)
SI (1) SI1841432T1 (https=)
UA (1) UA91204C2 (https=)
WO (1) WO2006059344A1 (https=)
ZA (1) ZA200704394B (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030010176A (ko) * 2001-07-25 2003-02-05 이병두 은행 열매 추출물과 호도 열매 추출물을 이용한 천식 치료제
CN101129381B (zh) * 2006-08-25 2012-02-01 天津和美生物技术有限公司 含β-内酰胺类抗生素和离子螯合剂的抗生素复方
CN101129382B (zh) * 2006-08-25 2013-12-25 天津和美生物技术有限公司 含β-内酰胺类抗生素和缓冲组分的抗生素复方
WO2010013640A1 (ja) * 2008-07-28 2010-02-04 Yamaguchi Keizo 感染症治療効果増強剤
CN101537009B (zh) * 2009-04-30 2010-09-15 海口奇力制药股份有限公司 注射用头孢曲松钠他唑巴坦钠复方制剂的生产工艺
JP2012176899A (ja) * 2009-05-19 2012-09-13 Mitsubishi Tanabe Pharma Corp 2−(1−ピペラジニル)−5−メチルベンゼンスルホン酸誘導体を含む注射用水溶液
PT2714034T (pt) * 2011-05-28 2018-10-30 Wockhardt Ltd Composições que compreendem cefepime e tazobactam
EP2768503A1 (en) * 2011-07-26 2014-08-27 Wockhardt Limited Pharmaceutical compositions comprising beta-lactam antibiotic, sulbactam and beta-lactamase inhibitor
WO2013042140A2 (en) * 2011-09-23 2013-03-28 Manu Chaudhary Non antibiotic,non peptide compounds for antibiotic efficacy & safety enhancement
KR101536885B1 (ko) 2012-03-26 2015-07-14 산텐 세이야꾸 가부시키가이샤 디쿠아포솔 함유 점안액
KR102083046B1 (ko) 2012-06-07 2020-02-28 칠드런'스 하스피틀 로스 앤젤레스 레티노이드 작용제를 이용하여 호중구감소증을 치료하기 위한 방법
RU2671485C2 (ru) * 2012-09-27 2018-11-01 Мерк Шарп И Доум Корп. Антибиотические композиции тазобактама аргинина
MX2016010699A (es) 2014-02-18 2017-10-11 Children's Hospital Los Angeles Composiciones y metodos para tratar neutropenia.
KR20160130824A (ko) * 2014-03-29 2016-11-14 욱크하르트 리미티드 세페파임 또는 술박탐을 포함하는 제약학적 조성물
WO2015151264A1 (ja) * 2014-04-03 2015-10-08 キユーピー株式会社 注射液用袋及び注射用製剤
US10201518B2 (en) 2016-09-28 2019-02-12 The University Of Hong Kong Bismuth(III) compounds and methods thereof
EP3429592A4 (en) * 2016-11-02 2019-10-30 Xiangbei Welman Pharmaceutical Co., Ltd COMPOSITION OF CEFTRIAXONNATRIUM AND SULBACTUMNATRIUM
CN111249284B (zh) * 2016-11-03 2022-10-04 湘北威尔曼制药股份有限公司 治疗淋病奈瑟菌感染的头孢曲松钠舒巴坦钠
RU2665006C1 (ru) * 2017-02-28 2018-08-24 Общество с ограниченной ответственностью "Супербаг Солюшенс" Композиция антимикробных препаратов для лечения инфекционных заболеваний людей и животных и способ её применения
SG11202101255UA (en) 2018-08-09 2021-03-30 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
EP4262860A4 (en) 2020-12-17 2025-11-12 Idexx Lab Inc DETECTION AND TREATMENT OF ROCKY MOUNTAIN SPRINKLE FEVER
WO2025165991A1 (en) * 2024-01-31 2025-08-07 The Penn State Research Foundation Biopolymeric anti-antibiotics and methods for making and using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6630510B1 (en) * 1999-10-28 2003-10-07 Merck & Co., Inc. Substituted succinic acid metallo-β-lactamase inhibitors and their use in treating bacterial infections
US6677320B2 (en) * 2000-01-20 2004-01-13 Hoffmann-La Roches Inc. Parenteral bisphosphonate composition with improved local tolerance
DK1468697T3 (da) * 2003-04-14 2008-04-14 Wyeth Corp Sammensætninger indeholdende piperacillin og tazobactam, der er anvendelige til injektion

Similar Documents

Publication Publication Date Title
JP2008521884A5 (https=)
JP2008530082A5 (https=)
TWI342212B (en) Liquid pharmaceutical formulations of palonosetron
US6028222A (en) Stable liquid paracetamol compositions, and method for preparing same
RU2007124325A (ru) Композиции для преодоления опосредованной бета-лактамазой резистентности к антибиотикам с использованием ингибитора бета-лактамазы, предназначенные для инъекции
CN1289084C (zh) 药物制剂
JP6745798B2 (ja) パラセタモール及びイブプロフェンを含む水性配合物
CN1396828A (zh) 含有培美西德以及一硫代甘油l-半胱氨酸或巯乙酸的药物组合物
JP2026027477A (ja) リファブチンの処置方法、使用および組成物
BRPI0612447A2 (pt) composição antibiótica de dose fixa, processo para a preparação de um produto de combinação antibiótica de dose fixa, processo para a preparação de uma injeção lìquida e usos de pó seco para injeção e injeção lìquida
EP2588097B1 (en) Pharmaceutical compositions comprising paracetamol and process for preparing the same
US9125905B2 (en) Liquid pharmaceutical formulations of palonosetron
JP5203191B2 (ja) エンド−n−(9−メチル−9−アザビシクロ[3.3.1]ノン−3−イル)−1−メチル−1h−インダゾール−3−カルボキサミド塩酸塩の医薬製剤
CN114306218B (zh) 满足药学抑菌要求的经粘膜给药r-氯胺酮药物组合物
WO2009081283A2 (en) Aqueous formulations of acetaminophen for injection
JP5811404B2 (ja) セトロンを頬側経粘膜投与するための処方物(formulation)
JP2018048096A (ja) 液体製剤、及び、パロノセトロンの安定性を向上する方法
KR101169478B1 (ko) 용액 의약조성물
WO2014062568A2 (en) Amoxicillin formulation and method of using such formulation
WO2014083071A1 (en) Injectable liquid formulation of the combination of tramadol and paracetamol
JPWO2009075309A1 (ja) 製剤組成物
WO2024151603A1 (en) Hydromorphone formulations for multi-dose products
EP4683646A1 (en) Stable aqueous ready-to-use composition of hydroxocobalamin
US20250319066A1 (en) Injectable dmt formulations
WO2007069070A2 (en) Aseptically filled multidose injectable dosage forms of granisetron